Skip to main content
OpenTrials

Clinical trial condition

Non-small Cell Lung Cancer Stage III

Explore clinical trials studying Non-small Cell Lung Cancer Stage III. Study availability and eligibility vary by location and protocol.

21 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Non-small Cell Lung Cancer Stage III trial results

Recruiting

Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node Involvement

NCT06449313

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Lombardi Comprehensive Cancer Center, Georgetown University Washington D.C., District of Columbia, United States
  • Washington University School of Medicine-Sitemen Cancer Center St Louis, Missouri, United States
  • UVA Comprehensive Cancer Center Charlottesville, Virginia, United States
View Trial Details
Recruiting

Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer

NCT06463665

Conditions
Advanced Non-squamous Non-small-cell Lung Cancer, Advanced Squamous Non-Small Cell Lung Carcinoma, Bronchial Neoplasms, +23 more
Locations
  • Pioneer Research Center, LLC Bullhead City, Arizona, United States
  • Clermont Oncology Center Clermont, Florida, United States
  • Oncology & Hematology Associates of West Broward Coral Springs, Florida, United States
  • Helios Clinical Research Fort Lauderdale, Florida, United States
View all 15 locations
View Trial Details
Recruiting

Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy

NCT05398094

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Hospital General Universitario de Alicante Alicante, Spain
  • ICO Badalona, Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
  • Hospital Universitari Quiron Dexeus Barcelona, Spain
  • Hospital Universitari Vall d' Hebron Barcelona, Spain
View all 20 locations
View Trial Details
Recruiting

Study of Antitumor Immune Response After cCRT and IO Treatment in Non-resectable III Stage NSCLC Patients

NCT06634199

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Complejo Hospitalario Universitario Del Ferrol Ferrol, A Coruña, Spain
  • Hospital General Universitario de Alicante Alicante, Spain
  • ICO Badalona, Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
  • Hospital Universitari Vall d' Hebron Barcelona, Spain
View all 22 locations
View Trial Details
Not Yet Recruiting

A Study Comparing BL-B01D1 in Combination With Osimertinib Versus Osimertinib Alone in Patients With Locally Advanced, Unresectable EGFR-mutated Non-small Cell Lung Cancer(Stage III) Whose Disease Has Not Progressed Following Definitive Platinum-based Chemoradiation Therapy(PANKU-Lung08)

NCT07640789

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Cancer Hospital of Shandong First Medical University Jinan, Shandong, China
View Trial Details

Related conditions